What do the results of the PRoFESS trial teach us?

Comment

. 2008 Oct;7(10):860-2.

doi: 10.1016/S1474-4422(08)70199-6. Epub 2008 Aug 29.

Comment

Graeme J Hankey et al. Lancet Neurol. 2008 Oct.

. 2008 Oct;7(10):860-2.

doi: 10.1016/S1474-4422(08)70199-6. Epub 2008 Aug 29.

No abstract available

Comment on

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Diener HC, et al. Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Lancet Neurol. 2008. PMID: 18757238 Free PMC article. Clinical Trial.

Anticoagulant therapy for patients with ischaemic stroke.
Hankey GJ. Hankey GJ. Nat Rev Neurol. 2012 May 8;8(6):319-28. doi: 10.1038/nrneurol.2012.77. Nat Rev Neurol. 2012. PMID: 22565207 Review.